SUNESIS PHARMACEUTICALS INC Severance Agreements
16 Contracts & Agreements
- Form of Executive Severance Benefits Agreement between Sunesis Pharmaceuticals, Inc. and certain officers (Filed With SEC on December 22, 2020)
- Executive Severance Benefits Agreement, dated May 4, 2020, by and between the Registrant and Tina Gullotta (Filed With SEC on August 11, 2020)
- Executive Severance Benefits Agreement, dated November 30, 2017, by and between the Registrant and William P. Quinn (Filed With SEC on March 9, 2018)
- THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on May 9, 2016)
- THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on May 9, 2016)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 6, 2014)
- SUNESIS PHARMACEUTICALS, INC. AMENDMENT TO EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 13, 2013)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 14, 2012)
- Exhibit A Executive Severance Benefits Agreement Exhibit B Indemnification Agreement (Filed With SEC on March 14, 2012)
- AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)
- AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)
- AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)
- AMENDED AND RESTATEDEXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)
- AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)
- AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on August 7, 2008)
